Prognostic Significance of the Baroreflex Sensitivity Changes After Acute Ischemic Stroke

The recruitment status of this study is unknown because the information has not been verified recently.
Verified July 2008 by Far Eastern Memorial Hospital.
Recruitment status was  Recruiting
Sponsor:
Information provided by:
Far Eastern Memorial Hospital
ClinicalTrials.gov Identifier:
NCT00422474
First received: January 14, 2007
Last updated: July 8, 2008
Last verified: July 2008
  Purpose

After acute stroke, baroreflex sensitivity (BRS) is impaired. This impaired acute stage BRS has been reported to be predictive of worsen outcome years after stroke in general. However, it is not very clear if the impaired acute stroke BRS would actually persist months after the acute stage. It is also not clear that such change, if any, would correlate with the functional outcome or prognosis after stroke.

The trial is to investigate the longitudinal time course of BRS after ischemic stroke up to the 6th month post stroke and to see if there is any correlation of the changes in BRS with the functional outcome parameters using NIHSS and mRS scores throughout this period.


Condition
Cerebrovascular Accident
Baroreflexes
Autonomic Nervous System Diseases

Study Type: Observational
Study Design: Time Perspective: Prospective
Official Title: Noninvasive Study of the Time Course of Baroreflex Sensitivity 6-Month After Acute Ischemic Stroke and the Relation of Its Changes With Post Stroke Prognosis

Resource links provided by NLM:


Further study details as provided by Far Eastern Memorial Hospital:

Estimated Enrollment: 100
Study Start Date: January 2007
  Eligibility

Ages Eligible for Study:   50 Years to 80 Years
Genders Eligible for Study:   Both
Accepts Healthy Volunteers:   No
Criteria

Inclusion Criteria:

  • Baroreflex sensitivity can be done within 72 hours of onset of acute ischemic stroke
  • 50-80 years old
  • Must have either brain CT or brain MRI done

Exclusion Criteria:

  • NIHSS score > 10
  • Patient could not cooperate
  • Unstable vital sign
  • Atrial fibrillation
  • Transient ischemic attack patient
  • Diabetic patient
  • Impaired renal function (Cr > 2.26 mg/dl)
  • Unstable angina, acute myocardiac infarction, cardiomyopathy patients
  • Patient who has known autonomic dysfunction
  Contacts and Locations
Choosing to participate in a study is an important personal decision. Talk with your doctor and family members or friends about deciding to join a study. To learn more about this study, you or your doctor may contact the study research staff using the Contacts provided below. For general information, see Learn About Clinical Studies.

Please refer to this study by its ClinicalTrials.gov identifier: NCT00422474

Contacts
Contact: Siupak Lee, M.D. siupakmd@ms1.hinet.net

Locations
Taiwan
Far Eastern Memorial Hospital Recruiting
Panchiao City, Taipei County, Taiwan, 220
Contact: Siupak Lee, M.D.       siupakmd@ms1.hinet.net   
Principal Investigator: Siupak Lee, M.D.         
Sub-Investigator: Lung Chan, M.D.         
Sub-Investigator: Dong-feng Yeih, M.D.         
Sponsors and Collaborators
Far Eastern Memorial Hospital
Investigators
Principal Investigator: Siupak Lee, M.D. Far Eastern Memorial Hospital
  More Information

No publications provided

Responsible Party: Dr. Siupak Lee, Far Eastern Memorial Hospital
ClinicalTrials.gov Identifier: NCT00422474     History of Changes
Other Study ID Numbers: FEMH-95-C-012
Study First Received: January 14, 2007
Last Updated: July 8, 2008
Health Authority: Taiwan: Department of Health

Keywords provided by Far Eastern Memorial Hospital:
Ischemic stroke
Baroreflex sensitivity
Prognosis
Cardiovascular autonomic regulation

Additional relevant MeSH terms:
Autonomic Nervous System Diseases
Primary Dysautonomias
Nervous System Diseases
Cerebral Infarction
Stroke
Brain Infarction
Brain Ischemia
Cerebrovascular Disorders
Brain Diseases
Central Nervous System Diseases
Vascular Diseases
Cardiovascular Diseases

ClinicalTrials.gov processed this record on October 01, 2014